Exhibit 99.3

ASML — Summary IFRS Consolidated Income Statements^1,2

	Three months ended,					Six months ended,
(in thousands EUR)	Jul 1, 2007			Jun 29, 2008		Jul 1, 2007			Jun 29, 2008
Net system sales		825,818			725,586		1,673,194			1,545,572
Net service and field option sales		104,405			118,571		205,700			217,793
Total net sales		930,223			844,157		1,878,894			1,763,365
Cost of sales		573,116			525,228		1,153,220			1,086,915
Gross profit on sales		357,107			318,929		725,674			676,450
Research and development costs, net of credits		97,692			87,066		191,350			169,789
Selling, general and administrative costs		56,317			55,331		112,473			113,027
Operating income		203,098			176,532		421,851			393,634
Interest income		5,167			4,973		12,483			8,548
Income before income taxes		208,265			181,505		434,334			402,182
Benefit from (provision for) income taxes		(53,789	)		28,986		(114,203	)		(25,231	)
Net income		154,476			210,491		320,131			376,951

ASML — Summary IFRS Consolidated Balance Sheets^1,2

(in thousands EUR)	Dec 31, 2007		Jun 29, 2008
ASSETS
Property, plant and equipment		380,894		458,100
Goodwill		136,246		127,274
Other intangible assets		216,908		260,478
Deferred tax assets		220,863		238,364
Derivative financial instruments		20,930		1,464
Other non-current assets		32,828		31,964
Total non-current assets		1,008,669		1,117,644
Inventories		1,102,210		1,130,239
Derivative financial instruments		12,319		46,559
Accounts receivables		637,975		516,886
Other current assets		193,415		185,945
Cash and cash equivalents		1,271,636		1,360,898
Total current assets		3,217,555		3,240,527
Total assets		4,226,224		4,358,171
EQUITY AND LIABILITIES
Equity		2,039,011		2,242,605
Other long-term debt		595,783		585,665
Derivative financial instruments		—		11,163
Deferred tax and other liabilities		257,325		260,202
Other deferred liabilities		7,935		7,366
Total non-current liabilities		861,043		864,396
Accounts payable		282,953		267,148
Accrued liabilities and other		927,841		910,803
Current tax liabilities		104,095		50,787
Derivative financial instruments		11,281		22,432
Total current liabilities		1,326,170		1,251,170
Total equity and liabilities		4,226,224		4,358,171

ASML — Summary IFRS Consolidated Statements of Cash Flows^1,2

	Three months ended,						Six months ended,
(in thousands EUR)	Jul 1, 2007			Jun 29, 2008			Jul 1, 2007			Jun 29, 2008
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		154,476			210,491			320,131			376,951
Depreciation and amortization		49,800			44,816			102,881			91,586
Disposal of property, plant and equipment		9,923			1,311			10,874			2,414
Share-based payments		4,362			2,873			6,667			6,277
Change in tax assets and liabilities		(2,798	)		(102,422	)		24,558			(72,669	)
Change in assets and liabilities		69,103			21,959			12,610			87,350
Net cash provided by operating activities		284,866			179,028			477,721			491,909
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(39,723	)		(65,441	)		(75,512	)		(120,473	)
Proceeds from sale of property, plant and equipment		—			—			3,355			—
Purchase of intangible assets		(13,017	)		(43,083	)		(35,479	)		(88,610	)
Acquisition of subsidiary (net of cash acquired)		—			—			(188,011	)		—
Net cash used in investing activities		(52,740	)		(108,524	)		(295,647	)		(209,083	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Purchase of shares in conjunction with conversion rights of bond holders and stock options		—			—			(156,253	)		(87,603	)
Dividend paid		—			(107,447	)		—			(107,447	)
Net proceeds from issuance of shares and stock options		10,629			553			26,397			3,528
Net proceeds from issuance of bonds		593,790			—			593,790			—
Redemption and/or repayment of debt		(111	)		—			(345	)		—
Net cash provided by (used in) financing activities		604,308			(106,894	)		463,589			(191,522	)
Net cash flows		836,434			(36,390	)		645,663			91,304
Effect of changes in exchange rates on cash		(387	)		144			(2,261	)		(2,042	)
Net increase (decrease) in cash and cash equivalents		836,047			(36,246	)		643,402			89,262

ASML — Quarterly Summary IFRS Consolidated Income Statements^1,2

	Three months ended,
	Jul 1,			Sep 30,			Dec 31,			Mar 30,			Jun 29,
(in millions EUR)	2007			2007			2007			2008			2008
Net system sales		825.8			843.2			834.9			820.0			725.6
Net service and field option sales		104.4			91.2			120.0			99.2			118.6
Total net sales		930.2			934.4			954.9			919.2			844.2
Cost of sales		573.1			581.9			583.7			561.7			525.3
Gross profit on sales		357.1			352.5			371.2			357.5			318.9
Research & development costs, net of credits		97.7			76.8			84.7			82.7			87.1
Selling, general and administrative costs		56.3			56.0			73.5			57.7			55.3
Operating income		203.1			219.7			213.0			217.1			176.5
Interest income (charges)		5.2			9.1			(2.2	)		3.6			5.0
Income before income taxes		208.3			228.8			210.8			220.7			181.5
Benefit from (provision for) income taxes		(53.8	)		(54.9	)		18.5			(54.2	)		29.0
Net income		154.5			173.9			229.3			166.5			210.5

ASML — Summary IFRS Consolidated Balance Sheets^1,2

	Jul 1,		Sep 30,		Dec 31,		Mar 30,		Jun 29,
(in millions EUR)	2007		2007		2007		2008		2008
ASSETS
Property, plant and equipment		313.5		343.3		380.9		401.4		458.1
Goodwill		148.9		141.7		136.3		127.2		127.3
Other intangible assets		190.6		198.4		216.9		238.0		260.5
Deferred tax assets		312.2		252.3		220.9		213.3		238.4
Derivative financial instruments		0.2		9.9		20.9		47.7		1.4
Other non-current assets		33.2		33.3		32.8		31.8		32.0
Total non-current assets		998.6		978.9		1,008.7		1,059.4		1,117.7
Inventories		972.9		1,021.2		1,102.2		1,152.0		1,130.2
Derivative financial instruments		12.8		23.5		12.3		36.5		46.6
Accounts receivables		567.8		611.7		638.0		741.5		516.9
Other current assets		184.6		211.8		193.4		202.4		185.9
Cash and cash equivalents		2,299.2		2,445.2		1,271.6		1,397.1		1,360.9
Total current assets		4,037.3		4,313.4		3,217.5		3,529.5		3,240.5
Total assets		5,035.9		5,292.3		4,226.2		4,588.9		4,358.2
EQUITY AND LIABILITIES
Equity		2,459.7		1,961.8		2,039.0		2,121.8		2,242.6
Convertible subordinated debt		339.8		40.1		—		—		—
Other long-term debt		587.6		597.8		595.8		609.1		585.6
Derivative financial instruments		15.6		0.7		—		—		11.2
Deferred tax and other liabilities		293.1		259.3		257.3		282.9		260.2
Other deferred liabilities		8.1		8.2		7.9		7.2		7.4
Total non-current liabilities		1,244.2		906.1		861.0		899.2		864.4
Accounts payable		311.4		320.9		283.0		479.6		267.2
Accrued liabilities and other		828.8		1,933.0		927.8		957.7		910.8
Current tax liabilities		184.2		151.9		104.1		111.5		50.8
Derivative financial instruments		7.6		18.6		11.3		19.1		22.4
Total current liabilities		1,332.0		2,424.4		1,326.2		1,567.9		1,251.2
Total equity and liabilities		5,035.9		5,292.3		4,226.2		4,588.9		4,358.2

ASML — Summary IFRS Consolidated Statements of Cash Flows^1,2

	Three months ended,
	Jul 1,			Sep 30,			Dec 31,			Mar 30,			Jun 29,
(in millions EUR)	2007			2007			2007			2008			2008
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		154.5			173.9			229.3			166.5			210.5
Depreciation and amortization		49.8			58.3			49.2			46.8			44.8
Disposal of property, plant and equipment		9.9			1.7			1.6			1.1			1.3
Share-based payments		4.4			3.7			6.8			3.4			2.9
Change in tax assets and liabilities		(2.8	)		4.0			(26.7	)		29.7			(102.4	)
Change in assets and liabilities		69.1			(6.3	)		(126.6	)		65.4			21.9
Net cash provided by operating activities		284.9			235.3			133.6			312.9			179.0
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(39.7	)		(49.7	)		(54.0	)		(55.1	)		(65.4	)
Proceeds from property, plant and equipment		—			—			1.7			—			—
Purchases of intangible assets		(13.0	)		(60.7	)		(40.4	)		(45.5	)		(43.1	)
Acquisition of subsidiary (net of cash acquired)		—			—			—			—			—
Net cash used in investing activities		(52.7	)		(110.4	)		(92.7	)		(100.6	)		(108.5	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Capital repayment		—			—			(1,011.9	)		—			—
Purchase of shares in conjunction with conversion rights of bond holders and stock options		—			—			(203.6	)		(87.6	)		—
Dividend paid		—			—			—			—			(107.5	)
Net proceeds from issuance of shares and stock options		10.6			25.4			11.5			3.0			0.6
Net proceeds from issuance of bonds		593.7			—			—			—			—
Redemption and/or repayment of debt		(0.1	)		(1.5	)		(7.9	)		—			—
Net cash provided by (used in) financing activities		604.2			23.9			(1,211.9	)		(84.6	)		(106.9	)
Net cash flows		836.4			148.8			(1,171.0	)		127.7			(36.4	)
Effect of changes in exchange rates on cash		(0.4	)		(2.8	)		(2.6	)		(2.2	)		0.2
Net increase (decrease) in cash and cash equivalents		836.0			146.0			(1,173.6	)		125.5			(36.2	)

ASML — Notes to the Summary IFRS Consolidated Financial Statements

Basis of Presentation

ASML has prepared the accompanying summary consolidated financial statements in accordance with International Financial Reporting Standards (“IFRS”) as adopted by the EU – accounting principles generally accepted in the Netherlands for companies quoted on Euronext Amsterdam. Further disclosures, as required under IFRS in annual reports and interim reporting (IAS 34), are not included. The accompanying consolidated financial statements are stated in thousands of euros (‘EUR’), except otherwise indicated.

For internal and external reporting purposes, ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). U.S. GAAP is ASML’s primary accounting standard for the Company’s setting of financial and operational performance targets.

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

ASML — Reconciliation U.S. GAAP — IFRS^1,2

Net income
	Three months ended,						Six months ended,
(in thousands EUR)	Jul 1, 2007			Jun 29, 2008			Jul 1, 2007			Jun 29, 2008
Net income under U.S. GAAP		159,505			191,977			312,180			337,100
Share-based payments (see Note 1)		(108	)		245			14			(518	)
Capitalization of development costs (see Note 2)		(2,701	)		18,649			19,981			40,330
Convertible subordinated notes (see Note 3)		(2,220	)		—			(4,396	)		—
Income taxes (see Note 4)		—			(380	)		(7,648	)		39
Net income under IFRS		154,476			210,491			320,131			376,951

Shareholders’ equity

	Jul 1,		Sep 30,		Dec 31,		Mar 30,			Jun 29,
(in thousands EUR)	2007		2007		2007		2008			2008
Shareholders’ equity under U.S. GAAP		2,318,002		1,831,438		1,890,948		1,958,159			2,060,575
Share-based payments (see Note 1)		3,924		7,126		787		(3,420	)		(3,266	)
Capitalization of development costs (see Note 2)		110,749		120,344		138,424		157,900			176,818
Convertible subordinated notes (see Note 3)		27,019		2,894		—		—			—
Income taxes (see Note 4)		—		—		8,852		9,186			8,478
Shareholders’ equity under IFRS		2,459,694		1,961,802		2,039,011		2,121,825			2,242,605

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options granted to its employees after November 7, 2002.

Under U.S. GAAP, until December 31, 2005, ASML accounted for stock option plans using the intrinsic value method in accordance with APB 25 “Accounting for stock issued to employees” and provided pro forma disclosure of the impact of the fair value method on net income and earnings per share in accordance with SFAS No. 123 “Accounting for Stock Based Compensation”. As of January 1, 2006, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, “Intangible Assets”. During the second half of 2004, ASML made changes to its administrative systems in order to provide sufficient information to comply with IFRS beginning from January 1, 2005. Sufficient reliable information to account for capitalization of development expenditures under IFRS before January 1, 2005 is not available. Under IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between 2 and 3 years. Amortization starts when the developed product is ready for volume production.

Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Convertible Subordinated Notes

Under IFRS, ASML applies IAS 32 “Financial instruments: Disclosure and presentation” and IAS 39 “Financial instruments: Recognition and measurement” beginning from January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts separately for the equity and liability component of its convertible notes (“Split accounting”). The equity component relates to the grant of a conversion option to shares to the holder of the bond. Split accounting results in additional interest charges.

Under U.S. GAAP, ASML accounts for its convertible bonds as a liability at the principal amount outstanding. As of December 31, 2007 ASML has no Convertible Subordinated Notes outstanding.

Note 4 Income taxes

Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12, unrealized net income resulting from intercompany transactions that is eliminated from the carrying amount of assets on consolidation gives rise to a temporary difference for which deferred taxes must be recognized on consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which prepaid taxes must be recognized on consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s tax jurisdiction.

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

1

All quarterly information in this press release is unaudited.

2

As of January 1, 2008 ASML has early adopted IFRIC 13 “Customer Loyalty Programmes”. IFRIC 13 requires award credits offered to its customers as part of a volume purchase agreement to be accounted for using the deferred revenue model. Until December 31, 2007 cost accrual method was used. ASML early adopted this interpretation because the deferred revenue model better reflects the business rationale for offering award credits. Comparative figures for 2007 were adjusted to reflect this change in accounting policy. The impact of this change on equity as per January 1, 2007 amounted to EUR 8.1 million (decrease) and on net income for the year 2007 and the first quarter of 2008 amounted to EUR 8.6 million (decrease) and EUR 0.1 million (increase) respectively.